跳至主要内容
临床试验/NCT05517993
NCT05517993尚未招募2 期

Effect of Gui-Lu-Er-Xian-Jiao-Wan on Intradialytic Hypotension: a Randomized Crossover Pilot Trial

Chang Gung Memorial Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Intradialytic hypotension episode

研究概览

简要总结

Intradialytic hypotension (IDH), a common complication during hemodialysis (HD) could increase patients' morbidity and mortality. Previous studies considered that some Chinese herbal medicine (CHM) plays a complementary role in reducing the frequency of IDH. This trial is aimed to investigate the effect of Gui-Lu-Er-Xian-Jiao-Wan (GLEXJW) in patients with intradialytic hypotension.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • End stage renal disease treated with hemodialysis for ≥3 months
  • Receive a standard thrice-weekly hemodialysis schedule
  • More than 25% of hemodialysis sessions complicated by intradialytic hypotension

排除标准

  • Active malignancy
  • Life-threatening conditions
  • Pregnancy
  • Recent participation in another clinical trial for intradialytic hypotension
  • History of hypersensitivity or contraindication to herbal medicine

研究组 & 干预措施

Group A

Experimental

Gui-Lu-Er-Xian-Jiao-Wan (GLEXJW) 3g orally twice daily for 12 weeks.

干预措施: Gui-Lu-Er-Xian-Jiao-Wan (Drug)

结局指标

主要结局

Intradialytic hypotension episode

时间窗: Each time of dialysis during 12-weeks study period.

Hypotension episode during hemodialysis

次要结局

  • Early termination of hemodialysis(Each time of dialysis during 12-weeks study period.)
  • SF-36(Baseline, 12 weeks, 28 weeks)

研究者

发起方
Chang Gung Memorial Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验